SEC Company Response from Profound Medical (PROF) — May 15, 2026
Profound Medical Corp.
Date: May 15, 2026 · CIK: 0001628808 · Accession: 0001104659-26-062367
AI Filing Summary & Sentiment
File numbers found in text: 333-295811
Show Raw Text
CORRESP 1 filename1.htm Profound Medical Corp. 2400 Skymark Avenue, Unit #6 Mississauga, Ontario L4W 5K5 May 15, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Conlon Danberg Re: Profound Medical Corp. Registration Statement on Form S-3 Filed May 12, 2026 File No.333-295811 Acceleration Request Ladies and Gentlemen: In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Profound Medical Corp., a corporation existing under the laws of Ontario, Canada (the "Registrant"), hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 to Tuesday, May 19, 2026, at 4:30 p.m., Eastern time, or as soon as thereafter practicable. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please contact Jeffrey P. Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request. Very truly yours, PROFOUND MEDICAL CORP. /s/ Rashed Dewan Rashed Dewan Chief Financial Officer cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Jeffrey P. Schultz Cheryl V. Reicin Eric Foster